University of California San Francisco, School of Medicine, San Francisco, California, USA.
Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, California, USA.
Facial Plast Surg Aesthet Med. 2022 Jan-Feb;24(1):54-59. doi: 10.1089/fpsam.2021.0060. Epub 2021 Sep 27.
Gender-affirming facial surgery (GFS) is becoming more widely available for transgender individuals, but data on surgical approaches and outcomes remain limited. Retrospective analysis of surgical outcomes among consecutive GFS cases performed at a tertiary care academic center between March 2016 and August 2020. Seventy-seven patients underwent 109 surgeries, including 478 individual procedures. The median age was 42 years. Ninety-five percent of patients had public health insurance. Two-stage GFS was often used in older patients ( = 0.001), with the first stage involving bone and cartilaginous alterations, and the second stage involving soft tissue procedures. Mean hospital stay after first-stage GFS was 1.2 days, with 70% discharged on postoperative day 1. Mean follow-up was 11.3 months. Among 66 patients with at least 1 month of follow-up, all complications were minor and included surgical site infection (5%), dehiscence (3.0%), seroma (3%), and medical complications (6%). Thirty-day hospital readmission rate was 1.5%. There are unique surgical approaches for GFS, which demonstrate low complication and readmission rates. Understanding these approaches and outcomes may help guide preoperative patient consultations and clinical decision making.
性别肯定性面部手术(GFS)在跨性别者中越来越普及,但有关手术方法和结果的数据仍然有限。 对 2016 年 3 月至 2020 年 8 月在一家三级护理学术中心进行的连续 GFS 病例的手术结果进行回顾性分析。 77 例患者接受了 109 次手术,包括 478 个单独的手术。中位年龄为 42 岁。95%的患者拥有公共医疗保险。两步 GFS 常用于老年患者( = 0.001),第一阶段涉及骨骼和软骨改变,第二阶段涉及软组织手术。第一阶段 GFS 后的平均住院时间为 1.2 天,有 70%的患者在术后第 1 天出院。平均随访时间为 11.3 个月。在至少有 1 个月随访的 66 名患者中,所有并发症均为轻度,包括手术部位感染(5%),裂开(3.0%),血清肿(3%)和医疗并发症(6%)。30 天的住院再入院率为 1.5%。 GFS 有独特的手术方法,其并发症和再入院率较低。了解这些方法和结果可能有助于指导术前患者咨询和临床决策。